SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-003064
Filing Date
2017-03-01
Accepted
2017-03-01 15:03:00
Documents
86
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nktr-10k_20161231.htm 10-K 3444638
2 EX-21.1 nktr-ex211_11.htm EX-21.1 5520
3 EX-23.1 nktr-ex231_6.htm EX-23.1 3949
4 EX-31.1 nktr-ex311_8.htm EX-31.1 8177
5 EX-31.2 nktr-ex312_7.htm EX-31.2 8159
6 EX-32.1 nktr-ex321_10.htm EX-32.1 7652
7 GRAPHIC g2017030114142400117154.jpg GRAPHIC 42190
  Complete submission text file 0001564590-17-003064.txt   11219406

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nktr-20161231.xml EX-101.INS 2364607
9 XBRL TAXONOMY EXTENSION SCHEMA nktr-20161231.xsd EX-101.SCH 82336
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20161231_cal.xml EX-101.CAL 81296
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20161231_def.xml EX-101.DEF 233539
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20161231_lab.xml EX-101.LAB 583124
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20161231_pre.xml EX-101.PRE 437082
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 17653530
SIC: 2834 Pharmaceutical Preparations